Filter
8285
Filtered Results: 8285
Text search:
Health
Safety
Featured
Recommendations
866
New Publications
2095
Language
Document type
No document type
4280
Guidelines
1270
Studies & Reports
1246
Manuals
487
Strategic & Response Plan
301
Fact sheets
270
Training Material
159
Situation Updates
99
Infographics
53
Resource Platforms
39
Brochures
32
Online Courses
28
Videos
19
App
2
Countries / Regions
India
319
Global
295
Kenya
211
Sierra Leone
200
Liberia
184
South Africa
170
Nigeria
150
Western and Central Europe
141
Ethiopia
141
Syria
136
Uganda
131
Nepal
130
Myanmar / Burma
130
Bangladesh
113
Latin America and the Carribbean
111
Africa
104
Malawi
94
Rwanda
90
Indonesia
90
Ukraine
89
Zambia
86
Ghana
82
Tanzania
80
Congo, Democratic Republic of
73
Philippines
70
South Sudan
69
Russia
63
Guinea
59
West and Central Africa
56
Namibia
56
Brazil
54
Middle East and North Africa
52
South–East Asia Region
48
Yemen
46
East and Southern Africa
45
Haiti
43
Zimbabwe
42
Lesotho
40
Senegal
40
Mozambique
40
Germany
38
Eastern Europe
36
Asia
35
Cambodia
34
Eastern Europe and Central Asia
34
Burkina Faso
33
Botswana
30
Afghanistan
26
Lebanon
26
Venezuela
24
Mali
24
Eswatini/ Swaziland
24
Sudan
23
Pakistan
23
USA
22
Jordan
19
Colombia
18
Cameroon
18
Western Pacific Region
18
Central African Republic
18
Angola
18
Vietnam
17
Somalia
15
Niger
14
Côte d’Ivoire / Ivory Coast
14
Madagascar
14
Guinea-Bissau
13
Thailand
12
China
12
Iraq
12
Tajikistan
11
Benin
11
Chile
11
Laos
11
Peru
11
Argentina
11
Moldova
11
Turkey
10
Palestine
10
Libya
10
Albania
9
United Kingdom
9
Chad
9
Ecuador
9
Spain
8
Kazakhstan
7
Sri Lanka
7
Greece
7
Paraguay
6
Portugal
6
Bolivia
6
Papua New Guinea
6
Bhutan
6
Gambia
5
Iran
5
Singapore
5
Kyrgyzstan
5
Saudi Arabia
5
North America
5
Timor Leste/ East Timor
4
El Salvador
4
Togo
4
Burundi
4
Turkmenistan
4
Japan
4
Southern Africa
4
Egypt
4
Romania
4
Georgia
4
Poland
4
North Macedonia
3
Mexico
3
Canada
3
Uzbekistan
3
Morocco
3
Qatar
3
Mauritania
3
Croatia
3
Mauritius
3
Tunisia
3
Belarus
3
Israel
3
Bosnia and Herzegovina
3
Guatemala
3
Serbia
2
Australia
2
Fiji
2
Estonia
2
Congo-Brazzaville
2
Italy
2
Dominican Republic
2
Hungary
2
Lithuania
2
Gabon
2
Jamaica
2
France
2
Nicaragua
2
Djibouti
2
Honduras
2
Switzerland
1
Malaysia
1
Mongolia
1
Bulgaria
1
Armenia
1
Ireland
1
Denmark
1
Belgium
1
Maldives
1
South Korea
1
Algeria
1
Azerbaijan
1
French Guyana
1
Latvia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
2851
Clinical Guidelines
650
Key Resources
509
Women & Child Health
480
Public Health
413
Capacity Building
198
Pharmacy & Technologies
113
Toolboxes
COVID-19
1111
Mental Health
590
HIV
453
Ebola
369
Planetary Health
308
TB
295
Conflict
293
Caregiver
290
AMR
279
Rapid Response
264
Disability
253
Refugee
206
Pharmacy
206
Natural Hazards
157
Global Health Education
137
NTDs
127
NCDs
114
Specific Hazards
67
Cholera
57
Zika
52
Polio
41
Health Financing Toolbox
34
Social Ethics
23
Typhoon
4
South Sudan
2
Health Financing
1
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2017 for Ghana has been deriv...
West Africa is experiencing the largest, most severe, most complex outbreak of Ebola virus disease in history. On 11 August 2014, WHO convened a consultation where the participants concluded that in the particular context of the current Ebola outbreak in West Africa, it is ethically acceptable to of...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
WHO Regional Publications, Western Pacific Series No. 23
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
Faith-based organizations (FBOs) and leaders can play a major role in saving lives and reducing illness related to COVID-19. They are a primary source of support and comfort for their members. Often trusted more than governments or health-agencies, faith leaders can share health information to prot...
Migrants are less familiar in their new environment in which they temporarily live. They are prone to various social, psychological and emotional trauma in such situations, emanating from fear of neglect by the local community and concerns about wellbeing and safety of their families waiting in thei...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-...
The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components.
The minimum requirements are defined as: I...
15 January 2021
This Aide Memoire is for policy makers, immunization programme managers, infection prevention and control (IPC) focal points at national, sub-national, and facility level, as well as for health workers involved in COVID-19 vaccination delivery. This document summarizes the key IPC p...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
People-centered approaches that help communities maintain protective behaviours and follow guidelines set out by public health and government agencies are more important than ever. The evidence is clear, communities play a role in preventing and controlling epidemics and they are best able to take a...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
Tackling COVID-19 misinformation. Ensuring communities have access to lifesaving public health information from trusted sources and are not misled by misinformation is essential to ending the COVID-19 pandemic.
In an effort to empower doctors and nurses – some of the most effective and trusted...
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize ...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
